Newron Pharmaceuticals S.p.A. (SWX: NWRN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
8.57
+0.08 (0.94%)
Sep 4, 2024, 4:36 PM CET

Newron Pharmaceuticals Market Cap

Newron Pharmaceuticals has a market cap or net worth of 161.81 million as of September 4, 2024. Its market cap has increased by 62.50% in one year.

Market Cap
161.81M
Enterprise Value
195.15M
Revenue
8.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.57

Market Cap Chart

Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 161.81M, a decrease of -47.64%. That is a compound annual growth rate of -3.58%.

History

DateMarket Cap% Change
Sep 4, 2024161.62M82.96%
Dec 29, 202388.33M219.35%
Dec 30, 202227.66M-4.32%
Dec 30, 202128.91M-24.65%
Dec 30, 202038.37M-66.14%
Dec 30, 2019113.32M13.19%
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 30, 2015 Pro Pro
Dec 30, 2014 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition